News

MorphoSys has posted a net profit of EUR2.7m for the second quarter 2010 compared to net profit of EUR1.5m for the comparable period in 2009. Operating profit was

Methylphenidate is used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), and narcolepsy. Tris Pharma claimed that this is the first-ever generic ANDA approved by

Anturol gel Phase 3 trial conducted under a special protocol assessment (SPA) with FDA, was a double blind, randomised, parallel placebo-controlled multi-center study which evaluated the efficacy and

Genzyme said as per the final rule, these medications, including its Renvela (sevelamer carbonate), will not be included in the bundle until January 1, 2014. Renvela is indicated

Trophos said that the study demonstrates the potential for TRO40303 to protect heart tissue from ischemia-reperfusion injury induced when treating myocardial infarction. Trophos claimed that TRO40303 acts by

Prior to joining Caraco Pharmaceutical Laboratories, Mr Singh worked as senior vice president of business strategies at Caraco Pharmaceutical Laboratories from July 2007 to July 2010. Previously, Mr

Additionally, the NDA has also been granted a priority review designation by the FDA, which means the review period for the NDA is reduced, which allows for the

Reportedly, since 2007, Mediomics has received over one million dollars of STTR funding to develop its quick and sensitive homogenous PINCER protein assay. Mediomics is currently focused on

PPD has posted a net income of $21m for the second quarter of 2010 or $0.18 per diluted share, compared to $58.1m or $0.49 per diluted share, for